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The authors pooled data from 15 case-control studies of head and neck cancer (9,107 cases, 14,219 controls) to
investigate the independent associations with consumption of beer, wine, and liquor. In particular, they calculated
associations with different measures of beverage consumption separately for subjects who drank beer only (858
cases, 986 controls), for liquor-only drinkers (499 cases, 527 controls), and for wine-only drinkers (1,021 cases,
2,460 controls), with alcohol never drinkers (1,124 cases, 3,487 controls) used as a common reference group. The
authors observed similar associations with ethanol-standardized consumption frequency for beer-only drinkers
(odds ratios (ORs) ¼ 1.6, 1.9, 2.2, and 5.4 for 5, 6–15, 16–30, and >30 drinks per week, respectively;
Ptrend < 0.0001) and liquor-only drinkers (ORs ¼ 1.6, 1.5, 2.3, and 3.6; P < 0.0001). Among wine-only drinkers,
the odds ratios for moderate levels of consumption frequency approached the null, whereas those for higher
consumption levels were comparable to those of drinkers of other beverage types (ORs ¼ 1.1, 1.2, 1.9, and
6.3; P < 0.0001). Study findings suggest that the relative risks of head and neck cancer for beer and liquor are
comparable. The authors observed weaker associations with moderate wine consumption, although they cannot
rule out confounding from diet and other lifestyle factors as an explanation for this finding. Given the presence of
heterogeneity in study-specific results, their findings should be interpreted with caution.
alcohol drinking; alcoholic beverages; beer; case-control studies; head and neck neoplasms; meta-analysis; wine
Abbreviations: CI, confidence interval; HNC, head and neck cancer; INHANCE, International Head and Neck Cancer Epidemiol-
ogy; OR, odds ratio.
Alcohol consumption is a major risk factor for head and
neck cancer (HNC), that is, cancers of the oral cavity, phar-
ynx, and larynx (1, 2). Although the causal mechanism is
not fully understood, ethanol may influence cancer risk di-
rectly through topical carcinogenic effects and/or indirectly
by enhancing the effects of other carcinogens (e.g., tobacco)
(1–3). There is speculation that other ingredients of alco-
holic beverages besides ethanol may additionally influence
cancer risk. Asbestos filtration products, tannins, N-nitroso
compounds, urethane, and other possible carcinogens have
been found in some alcoholic beverages (1, 3). Conversely,
antioxidants, such as resveratrol, found in red wine may be
anticarcinogenic (4).
In light of this uncertainty surrounding the mechanisms
underlying alcohol-induced carcinogenesis, there has been
interest as to whether different alcoholic beverages are
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differentially associated with HNC risk. There are several
reports of differences in relative risk among beer, wine, and
liquor consumption (Web Table 1). (This information is de-
scribed in the first of 6 supplementary tables; each is re-
ferred to as ‘‘Web table’’ in the text and is posted on the
Journal’s website (http://aje.oxfordjournals.org/).) How-
ever, the observed differences in risk are inconsistent across
studies (5–17). A common limitation of these studies is the
inability to adequately isolate the effects of beer, wine, and
liquor consumption, given their intercorrelated patterns of
consumption in many populations. One method of address-
ing this issue is to identify drinkers of only beer, wine, or
liquor and to estimate their respective associations with
HNC risk relative to never drinkers. However, limitations
in sample size among individual studies have prevented the
use of this analytical approach across all 3 beverage types.
Larger studies are needed to adequately investigate the
effects of different alcoholic beverages; with this in mind,
we conducted a pooled analysis of studies participating in
the International Head and Neck Cancer Epidemiology
(INHANCE) Consortium to investigate the independent as-
sociations with HNC risk for consumption of beer, wine,
and liquor. In particular, we estimated these associations
among persons who consumed 1 beverage type exclusively
(referred to hereafter as ‘‘pure drinkers’’).
MATERIALS AND METHODS
A detailed description of the INHANCE Consortium has
been previously published (18). For the purposes of this
study, HNC cases were restricted to invasive tumors of the
oral cavity, oropharynx, hypopharynx, oral cavity or phar-
ynx not otherwise specified, larynx, and HNC unspecified
(18). Cancers of the salivary gland (International Classifi-
cation of Diseases for Oncology, Second Edition, codes
C07–C08) were excluded from our analysis because of the
different etiologic pattern from that of other HNCs. The
INHANCE pooled data set (version 1.1) used for this anal-
ysis included 15 individual case-control studies, comprising
10,301 HNC cases and 15,329 controls (19–32). Individuals
with missing data on age, sex, or race/ethnicity were ex-
cluded (23 cases, 102 controls), as were subjects with miss-
ing or conflicting information regarding drinking status (620
cases, 390 controls). Finally, participants from the India and
Sudan centers of the International Agency for Research on
Cancer Multicenter Study (32) were excluded (551 cases,
618 controls) because of the extremely low prevalence of
alcohol consumption in these populations. After these ex-
clusions, the data set for this analysis included 9,107 HNC
cases and 14,219 controls.
Characteristics of the studies included in the pooled data
are shown in Table 1. Most were hospital based, and all
included controls frequency matched to cases on age, sex,
and additional factors. Study interviews were conducted
face-to-face, except in Iowa where subjects completed
self-administered questionnaires. Written, informed consent
was obtained from all study subjects, and the investigations
were approved by institutional review boards at each of the
institutes involved. All study questionnaires were reviewed
to assess the comparability of the data and wording of in-
terview questions. The questionnaires were conceptually
similar across studies; subjects were asked if they were
alcohol drinkers (definitions by study are included in the
Appendix) and then asked subsequent questions on fre-
quency of drinking, duration of drinking, and different types
of alcoholic beverages consumed. Data from individual
studies were received by the pooling center with personal
identifiers removed. Each data item was checked for illog-
ical or missing values. Queries were sent to investigators,
and inconsistencies were resolved.
To facilitate comparisons of consumption frequency
across alcoholic beverage types and to adjust for differences
between studies in specified beverage volumes, we stan-
dardized the calculated average beverage-specific weekly
number of drinks on the basis of ethanol volume. We cal-
culated this measure for each alcoholic beverage type by
converting the beverage volume specified in the question-
naire to milliliters, multiplying this by the average number
of drinks per week of that beverage, applying estimates of
the beverage-specific volume percentage of pure ethanol
(5% for beer, 12% for wine, 40% for liquor) (1), and di-
viding the weekly consumption of pure ethanol by the av-
erage per-drink volume of pure ethanol across alcoholic
beverage types for the 15 studies (15.6 mL). The standard-
ized estimates of beverage consumption frequency can thus
be assumed to have, on average, identical volumes of etha-
nol per drink.
The cutpoints for categorizing the average weekly num-
ber of ethanol-standardized drinks for a beverage (never
drinker, 5, 6–15, 16–30, >30 drinks per week) were se-
lected to maximize the number of categories of consumption
level while minimizing the occurrence of sparse data within
the upper categories for some studies. This latter issue arose
because of considerable variation across populations in the
popularity of different beverages, as is summarized in Table 1.
Participants in European studies consumed larger quantities
of wine than did subjects from North and Latin America.
Less extreme differences were observed for liquor con-
sumption (generally higher in North and Latin American
studies), while beer consumption was fairly uniform across
studies. For each alcoholic beverage, we also calculated the
duration (never drinker, 10, 11–20, 21–40, >40 years) of
consumption reported by subjects and the lifetime cumula-
tive number of standardized drinks consumed (never
drinker, 10, 11–20, 21–40, 41–80, >80 drink-years; cal-
culation previously described (18)).
From the data on alcohol consumption, we were able to
identify mutually exclusive subgroups across studies: never
drinkers (1,124 cases, 3,487 controls), drinkers of beer only
(858 cases, 986 controls), drinkers of liquor only (499 cases,
527 controls), drinkers of wine only (1,021 cases, 2,460
controls), and drinkers of multiple beverage types (5,605
cases, 6,759 controls). Our analyses focused on investiga-
tions of alcoholic beverage consumption (ethanol-standardized
consumption frequency, duration of consumption, lifetime
cumulative consumption) among each of the groups of pure
drinkers, with never drinkers as a common reference group.
However, we also examined associations with beverage-
specific, ethanol-standardized consumption frequency
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19 Milan, Italy 1984–1989 <80 Oral cavity,
pharynx, larynx
Hospital 95c Hospital—unhealthy 95c 0 0 21
20 Aviano, Italy 1984–1989 >18 Oral cavity,
pharynx, larynx
Hospital >95c Hospital—unhealthy 95c 0 0 28
21 France 1987–1992 N/R Oral cavity,
pharynx, larynx
Hospital 95c Hospital—unhealthy 95c 7 0 28
22 Aviano, Milan,
and Latina, Italy
1990–1999 18–80 Oral cavity,
pharynx, larynx
Hospital >95 Hospital—unhealthy 95 1 1 19
23 Switzerland 1991–1997 <80 Oral cavity,
pharynx, larynx
Hospital 95 Hospital—unhealthy 95 0 0 12
24 Central Europe 1998–2003 15 Oral cavity,
pharynx, larynx
Hospital 96 Hospital—unhealthy 97 2 5 1
United States




54, 63d Random digit dialing 63, 61d 2 1 1
26 Iowa 1993–2006 >17 Oral cavity,
pharynx, larynx
Hospital 87 Hospital—healthy 92 6 1 0
27 North Carolina 1994–1997 >17 Oral cavity,
pharynx, larynx
Hospital 88 Hospital—unhealthy 86 4 2 0




90 1 1 1




49 Neighborhood 68 2 1 1
30 Houston, TX 2001–2006 N/R Oral cavity,
pharynx, larynx
Hospital 95 Hospital visitors >80 4 1 0
Latin America




71 Residential records 83 9 5 0
Latin Americae 2000–2003 15–79 Oral cavity,
pharynx, larynx
Hospital 95 Hospital—unhealthy 86 7 0 0
Cross-regionalf




1992–1997 N/R Oral cavity,
pharynx
Hospital 89 Hospital/community 87 1 1 3
Abbreviations: INHANCE, International Head and Neck Cancer Epidemiology; N/R, no age restriction.
a Representative publication in which the study methods are available.
b All studies frequency matched controls to cases minimally on age and sex. Additional frequency matching factors included center (Italy, Central Europe, Latin America, and International
Multicenter studies), hospital (France study), ethnicity (Tampa and Los Angeles studies), and neighborhood (Los Angeles study).
c The participation rate was not formally assessed; the estimated response rate is reported.
d Two response rates are reported because data were collected in 2 population-based case-control studies, the first from 1985 to 1989 amongmen and the second from 1990 to 1995 among
men and women.
e Study centers: Buenos Aires, Havana, Goiãnia, Pelotas, Porto Alegre, Rio de Janeiro, and São Paolo.





































among all study subjects (i.e., including drinkers of multiple
beverage types).
We used a 2-stage random effects modeling approach (33)
for our pooled analysis of alcoholic beverage types. At the
first stage, associations between HNC and measures of al-
coholic beverage consumption were assessed by estimating
odds ratios and 95% confidence intervals based on uncon-
ditional logistic regression models for each case-control
study. To adjust for matching factors and potential confound-
ing, we included age (categories shown in Web Table 2),
sex, education, race/ethnicity, study center, pack-years of
cigarette smoking, years of cigar smoking (continuous),
and years of pipe smoking (continuous) in all models. Anal-
yses conducted among all study subjects (i.e., including
drinkers of multiple beverage types) were also adjusted
for consumption frequency of other beverages. For subjects
missing information on educational level (535 cases, 438
controls), we applied multiple imputation using the PROC
MI procedure (SAS, version 9, software; SAS Institute, Inc.,
Cary, North Carolina) under the assumption that the educa-
tion data were missing at random (34). Within each geo-
graphic region, we predicted educational level using logistic
regression models with parameters for age, sex, race/ethnicity,
study, and case/control status (35). The logistic regression
results to assess summary estimates for alcoholic beverage
consumption for the 5 imputations were combined by using
the PROC MIANALYZE procedure (SAS Institute, Inc.).
At the second stage of analysis, summary effect estimates
were calculated by using a maximum-likelihood–based ran-
dom effects model. We tested for evidence of heterogeneity
between the study-specific odds ratios for categories of al-
coholic beverage use by calculating likelihood ratio tests
comparing the deviance statistics from main-effects models
with those from models specifying interaction between al-
coholic beverage consumption and study.
Among pure drinkers, we conducted a test of heterogene-
ity in odds ratio estimates for levels of ethanol-standardized
consumption frequency across the 3 beverage types. This
was performed by constructing a likelihood ratio test com-
paring the deviance statistic of a model containing bever-
age-specific parameters for consumption frequency with
that of a constrained model with parameters for different
levels of consumption frequency specified as being identical
across beverage types.
We also conducted additional analyses stratifying by geo-
graphic region (Europe, North America, Latin America),
Figure 1. Study-specific head and neck cancer odds ratios for consumption of separate alcoholic beverages—pure drinkers versus never
drinkers. Diamond symbols represent odds ratios; symbol size is proportional to the number of cases among never drinkers and pure drinkers
of that beverage. Horizontal lines represent 95% confidence intervals. The P value for the test of heterogeneity across individual studies is shown at
the bottom of each graph. OR, odds ratio; Int., International.
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study design (hospital based, population based), cancer site
(oral, pharynx, larynx), smoking history (never smoked,
ever smoked), sex, and age (<55, 55 years). We also con-
ducted influence analyses, where each study was excluded
one at a time to assess the impact upon the magnitude of the
overall summary estimate and its statistical significance.
All reported P values are 2 sided.
RESULTS
Of the 9,107 cases and 14,219 controls included in the
analysis, approximately 88%and 75%, respectively, reported
alcohol consumption. The majority of drinkers reported con-
suming multiple beverage types (70% of case drinkers, 63%
of control drinkers). Among pure drinkers, the most common
beverage reported was wine (43% of case pure drinkers, 62%
of control pure drinkers), followed by beer (36% of case pure
drinkers, 25% of control pure drinkers) and liquor (21% of
case pure drinkers, 13% of control pure drinkers). Selected
characteristics of cases and controls are shown in Web Table
2. As expected, the distribution of pure beverage consump-
tion differed substantially by geographic region; themajority
of wine-only drinkers were European (83% of cases, 87% of
controls), and most beer-only drinkers were North American
(71% of cases, 53% of controls). Pure liquor consumption
varied by geographic region to a lesser extent than for beer
and wine; a plurality of liquor-only drinkers were from North
America (45% of cases, 46% of controls). Pure drinkers and
multiple-beverage drinkers were similar in their distributions
by age, sex, ethnicity, educational level, and pack-years of
cigarette use. Women and never smokers were less likely to
consume alcohol.






























5 215 414 1.6 (1.3, 2.1) 161 276 1.6 (1.0, 2.6) 128 477 1.1 (0.8, 1.6)
6–15 228 304 1.9 (1.4, 2.7) 116 121 1.5 (1.0, 2.4) 157 722 1.2 (0.8, 1.9)
16–30 136 146 2.2 (1.3, 3.5) 97 70 2.3 (1.4, 4.0) 209 733 1.9 (0.9, 3.9)
>30 279 122 5.4 (3.1, 9.2) 125 60 3.6 (2.2, 5.8) 527 527 6.3 (2.2, 18.6)
Ptrend <0.0001 <0.0001 <0.0001
Pheterogeneity
b 0.002 0.02 <0.0001
Years of consumption
10 82 134 1.8 (1.2, 2.6) 37 70 1.5 (0.8, 2.7) 40 131 1.5 (0.9, 2.5)
11–20 80 159 1.5 (1.0, 2.1) 42 66 1.5 (0.8, 2.6) 46 183 1.6 (0.8, 3.2)
21–40 462 496 2.5 (1.7, 3.6) 233 255 2.1 (1.3, 3.5) 519 1,237 1.9 (1.2, 3.0)
>40 225 189 2.2 (1.6, 3.0) 184 134 2.6 (1.6, 4.3) 410 898 1.7 (0.9, 3.2)
Ptrend 0.40 0.24 0.46




10 177 335 1.8 (1.4, 2.3) 103 219 1.3 (0.8, 1.9) 75 367 1.0 (0.7, 1.4)
11–20 77 145 1.6 (1.1, 2.4) 62 94 1.5 (0.8, 2.6) 50 162 1.6 (1.0, 2.8)
21–40 115 168 2.1 (1.5, 3.0) 73 75 1.7 (1.0, 2.8) 65 313 1.1 (0.7, 1.8)
41–80 132 152 1.9 (1.3, 2.7) 88 51 3.6 (1.9, 6.9) 118 529 1.4 (0.7, 2.9)
>80 348 178 4.0 (2.5, 6.6) 170 86 2.9 (1.8, 4.7) 707 1,078 4.0 (1.8, 9.0)
Ptrend 0.005 0.21 <0.0001
Pheterogeneity 0.0006 0.03 <0.0001
Abbreviations: CI, confidence interval; INHANCE, International Head and Neck Cancer Epidemiology.
a Odds ratios adjusted for age, sex, race/ethnicity, study center, educational level, pack-years of smoking, years of cigar smoking, and years of
pipe smoking.
b P value for the test of odds ratio heterogeneity across studies.
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Analyses of pure drinkers of each beverage type
Figure 1 shows study-specific odds ratios for beer, liquor,
and wine consumption (vs. alcohol never drinkers) from
analyses restricted to alcohol never drinkers and pure
drinkers. The study-specific odds ratios were fairly homo-
geneous for beer but not for liquor or wine; tests of between-
study heterogeneity for the latter 2 beverage types were
statistically significant. In particular, the heterogeneity for
wine consumption was greatest among the European stud-
ies. The random effects summary odds ratios for ever drink-
ing of beer, liquor, and wine were 2.1 (95% confidence
interval (CI): 1.6, 2.7), 2.2 (95% CI: 1.4, 3.4), and 1.6
(95% CI: 1.0, 2.6), respectively.
The results from pooled analyses of ethanol-standardized
beverage consumption frequency and duration among pure
drinkers of each beverage type are summarized in Table 2.
All summary odds ratio estimates demonstrated between-
study heterogeneity. We observed similar associations with
HNC risk among beer-only drinkers (odds ratios (ORs) ¼
1.6, 1.9, 2.2, and 5.4 for 5, 6–15, 16–30, and >30 drinks
per week, respectively) and liquor-only drinkers (ORs ¼
1.6, 1.5, 2.3, and 3.6) relative to never drinkers. Associations
with years of consumption and lifetime cumulative con-
sumption were also comparable between beer-only and
liquor-only drinkers. Among wine-only drinkers, odds ratios
for moderate levels of consumption were close to null (ORs ¼
1.1 and 1.2 for 5 and 6–15 drinks per week, respectively);
increases in risk were observed only for higher consumption
levels (ORs ¼ 1.9 and 6.3 for 16–30 and >30 drinks per
week, respectively). A test of heterogeneity in odds ratio
estimates for levels of consumption frequency across all 3
beverage types was statistically significant (P < 0.01).
When we conducted pairwise tests of heterogeneity between
beverage types, it became apparent that the odds ratio esti-
mates for wine-only drinkers were the source of the hetero-
geneity (beer vs. liquor, P ¼ 0.60; beer vs. wine, P < 0.01;
liquor vs. wine, P ¼ 0.02).
Study-specific results (Web Tables 3–5) were inspected,
and influence analyses were performed to attempt to identify
sources of between-study heterogeneity in the pooled
estimates of ethanol-standardized beverage consumption
Table 3. Head and Neck Cancer Risk and Pure Ethanol-standardized Consumption of Beer, With Analysis Stratified by Selected Study and
Subject Characteristics, in the INHANCE Consortium























North America 537 1,477 296 383 2.0 (1.5, 2.6) 316 144 4.1 (2.2, 7.6) 0.45
Latin America 305 712 104 216 1.5 (0.7, 3.2) 67 89 2.1 (0.8, 5.7) 0.15
Europe 277 1,285 42 117 1.4 (0.6, 3.2) 32 35 3.5 (1.2, 10.4) 0.10
Study design
Hospital based 1,007 3,080 377 566 1.8 (1.4, 2.2) 360 221 3.4 (2.1, 5.6) <0.01
Population based 117 407 66 152 1.7 (0.6, 4.7) 55 47 3.1 (0.7, 13.1) 0.01
Cancer sitec
Oral cavity 344 3,487 108 718 2.0 (1.4, 2.8) 120 268 6.4 (3.9, 10.3) 0.15
Pharynx 330 3,487 167 718 2.3 (1.7, 3.1) 151 268 4.3 (2.7, 6.8) 0.42
Larynx 285 3,487 116 718 1.6 (1.1, 2.2) 97 268 2.7 (1.7, 4.4) 0.29
Ever smoked cigarettes
No 480 2,124 77 271 1.2 (0.8, 1.8) 22 46 1.9 (0.9, 4.1) 0.40
Yes 644 1,360 366 447 2.3 (1.8, 3.0) 393 221 4.1 (2.5, 6.7) <0.01
Sex
Males 513 1,698 329 578 1.7 (1.3, 2.2) 366 249 3.6 (2.4, 5.4) 0.23
Females 611 1,789 114 140 2.1 (1.4, 3.1) 49 19 2.1 (0.3, 13.5) <0.01
Age, years
<55 381 1,448 192 376 1.9 (1.4, 2.7) 170 137 3.6 (2.1, 6.0) 0.31
55 743 2,039 251 342 1.7 (1.3, 2.2) 245 131 3.5 (2.3, 5.2) 0.03
Abbreviations: CI, confidence interval; INHANCE, International Head and Neck Cancer Epidemiology.
a P value for test of odds ratio heterogeneity across studies.
b Odds ratios adjusted for age, sex, race/ethnicity, study center, educational level, pack-years of smoking, years of cigar smoking, and years of
pipe smoking.
c Excludes 415 cancers without site information, of overlapping head and neck sites, or of oral cavity/pharynx, not otherwise specified.
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frequency among pure drinkers and never drinkers. The sum-
mary odds ratios for beer-only consumption were influenced
slightly by exclusion of the Iowa study (OR ¼ 1.6, 1.7, 1.7,
and 4.2 for 5, 6–15, 16–30, and >30 drinks per week, re-
spectively), although statistically significant between-study
heterogeneity remained (P < 0.0001). Exclusion of the
Tampa study influenced the pooled results for consumption
of liquor only (ORs ¼ 1.5, 1.8, 1.9, and 3.2); no residual
between-study heterogeneity was detected (P ¼ 0.15). The
associations with pure wine consumption became consider-
ably weaker in magnitude upon exclusion of the Switzerland
study (ORs ¼ 1.0, 1.0, 1.4, and 3.7) and increased with ex-
clusion of the Milan study (ORs ¼ 1.2, 1.4, 2.4, and 8.7); in
each case, however, substantial heterogeneity was still pres-
ent among the remaining pooled studies.
The results of stratified analyses of pure ethanol-standard-
ized beverage consumption level (never drinker, 15, >15
drinks per week) are summarized in Tables 3–5.We observed
some differences between geographic regions in the magni-
tude of risk for the highest consumption level. For beer,
summary odds ratio estimates for North American studies
(ORs ¼ 2.0 and 4.1 for 15 and >15 standard drinks per
week, respectively) were slightly stronger than those for
studies from Europe (ORs ¼ 1.4 and 3.5) and Latin America
(ORs ¼ 1.5 and 2.1). For liquor, the summary odds ratio
estimates for North American studies (ORs ¼ 1.9 and 3.2)
and Latin American studies (ORs ¼ 2.1 and 2.6) were
stronger than those of studies from Europe (ORs ¼ 1.2
and 1.7). For wine, the odds ratio estimates for European
studies (ORs ¼ 1.5 and 4.0) were stronger than those for
studies from North America (ORs ¼ 1.1 and 2.8) and Latin
America (ORs ¼ 1.1 and 3.7). Odds ratios were stronger for
oral and pharyngeal cancer than for laryngeal cancer and
among smokers compared with never smokers. The pattern
of associations across beverage types did not change with
anatomic site or smoking status. Additional analyses inves-
tigating the joint effects of smoking and pure beverage con-
sumption (ever vs. never drinker) also did not meaningfully
differ by beverage type (results not shown). Beverage asso-
ciations did not differ by study design, sex, or age group.
Table 4. Head and Neck Cancer Risk and Pure Ethanol-standardized Consumption of Liquor, With Analysis Stratified by Selected Study and
Subject Characteristics, in the INHANCE Consortium























North America 537 1,477 101 172 1.9 (0.8, 4.4) 123 69 3.2 (1.5, 6.6) 0.01
Latin America 305 712 34 25 2.1 (0.4, 9.6) 65 38 2.6 (0.6, 11.1) 0.97
Europe 277 1,285 142 199 1.2 (0.6, 2.5) 32 20 1.7 (0.4, 6.9) 0.02
Study design
Hospital based 1,007 3,080 241 317 1.6 (1.1, 2.2) 175 101 3.0 (2.0, 4.7) 0.01
Population based 117 407 36 80 2.3 (0.1, 43.6) 47 29 1.8 (0.1, 25.8) 0.02
Cancer sitec
Oral cavity 344 3,487 80 397 1.7 (0.9, 3.3) 53 130 3.2 (1.6, 6.4) 0.11
Pharynx 330 3,487 65 397 2.0 (0.9, 4.6) 86 130 3.6 (2.0, 6.3) <0.01
Larynx 285 3,487 108 397 1.6 (0.8, 3.1) 58 130 1.9 (0.9, 3.9) 0.06
Ever smoked cigarettes
No 480 2,124 30 123 1.2 (0.5, 2.9) 5 22 3.5 (0.5, 25.6) 0.20
Yes 644 1,360 247 273 1.8 (1.1, 3.0) 217 108 3.3 (1.8, 6.1) <0.01
Sex
Males 513 1,698 188 274 1.8 (1.2, 2.8) 181 110 3.0 (1.8, 5.7) <0.01
Females 611 1,789 89 123 1.1 (0.6, 2.0) 41 20 2.2 (0.9, 5.2) 0.13
Age, years
<55 381 1,448 75 137 1.0 (0.3, 2.7) 49 36 2.7 (1.0, 7.1) <0.01
55 743 2,039 202 260 1.8 (1.2, 2.6) 173 94 3.0 (2.0, 4.7) 0.20
Abbreviations: CI, confidence interval; INHANCE, International Head and Neck Cancer Epidemiology.
a P value for test of odds ratio heterogeneity across studies.
b Odds ratios adjusted for age, sex, race/ethnicity, study center, educational level, pack-years of smoking, years of cigar smoking, and years of
pipe smoking.
c Excludes 415 cancers without site information, of overlapping head and neck sites, or of oral cavity/pharynx, not otherwise specified.
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Analyses of all study subjects
In our pooled analysis of all study subjects, the pattern of
findings across alcoholic beverage types was comparable to
that observed in the analysis of pure drinkers (Web Table 6).
DISCUSSION
Overall, we found estimates of the relative risks of HNC
associated with alcohol consumption to be very similar for
beer and liquor. In light of our use of ethanol-standardized
estimates of beverage consumption frequency, our finding of
similar associations with risk for beer and liquor consump-
tion argues in favor of ethanol and its metabolites as the
principal carcinogenic agents in these alcoholic beverages,
rather than beverage-specific constituents. We cannot rule
out the possibility that another byproduct of alcohol produc-
tion—created at levels highly correlated with ethanol con-
centration—is in fact the actual HNC carcinogen in
alcoholic beverages. To our knowledge, no such candidate
compound has been identified.
Our summary odds ratio estimates for wine consumption,
however, were somewhat different from those for the other 2
beverage types. Whereas the dose-response relation was
generally linear for beer and liquor, no such trend was ob-
served for wine. At moderate levels of consumption, the
odds ratio estimates for wine were much weaker than the
corresponding estimates for beer or liquor. At a high con-
sumption level (>30 standard drinks per week), the odds
ratio estimate for wine was generally comparable to those
of the other beverage types. This pattern in risk across bev-
erage types was consistent across most subgroup strata with
nonsparse numbers, and it was also apparent in analyses of
all subjects (i.e., pure and mixed-beverage drinkers), sug-
gesting that these findings are not attributable to issues con-
cerning the study of pure drinkers.
One possible reason for the observed weaker association
with moderate wine consumption is that it reflects residual
confounding. Wine consumption has been associated with
Table 5. Head and Neck Cancer Risk and Pure Ethanol-standardized Consumption of Wine, With Analysis Stratified by Selected Study and
Subject Characteristics, in the INHANCE Consortium























North America 537 1,477 70 236 1.1 (0.7, 1.8) 12 9 2.8 (0.5, 15.5) 0.17
Latin America 305 712 39 52 1.1 (0.6, 1.9) 50 15 3.7 (1.7, 7.8) 0.03
Europe 277 1,285 173 907 1.5 (0.6, 3.4) 673 1,233 4.0 (1.4, 11.2) <0.01
Study design
Hospital based 1,007 3,080 267 1,121 1.2 (0.8, 1.9) 734 1,257 3.6 (1.8, 7.3) <0.01
Population based 117 407 18 78 1.2 (0.3, 5.1) 2 3 0.19
Cancer sitec
Oral cavity 344 3,487 83 1,199 1.3 (0.7, 2.2) 133 1,260 5.9 (2.3, 15.4) <0.01
Pharynx 330 3,487 77 1,199 1.4 (0.9, 2.2) 231 1,260 4.4 (2.0, 9.6) <0.01
Larynx 285 3,487 97 1,199 1.2 (0.6, 2.3) 298 1,260 3.9 (1.2, 13.0) <0.01
Ever smoked cigarettes
No 480 2,124 84 630 1.3 (0.8, 2.0) 38 420 1.6 (0.8, 3.1) <0.01
Yes 644 1,360 201 569 1.2 (0.7, 2.2) 698 840 3.7 (1.5, 9.1) <0.01
Sex
Males 513 1,698 155 615 1.1 (0.7, 1.9) 655 1,051 3.6 (1.4, 8.8) <0.01
Females 611 1,789 130 584 1.2 (0.7, 1.9) 81 209 3.6 (1.9, 6.8) <0.01
Age, years
<55 381 1,448 93 405 1.5 (1.0, 2.2) 198 430 2.8 (1.3, 5.8) 0.09
55 743 2,039 192 794 1.2 (0.7, 2.0) 538 830 3.6 (1.4, 8.9) <0.01
Abbreviations: CI, confidence interval; INHANCE, International Head and Neck Cancer Epidemiology.
a P value for test of odds ratio heterogeneity across studies.
b Odds ratios adjusted for age, sex, race/ethnicity, study center, educational level, pack-years of smoking, years of cigar smoking, and years of
pipe smoking.
c Excludes 415 cancers without site information, of overlapping head and neck sites, or of oral cavity/pharynx, not otherwise specified.
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higher intake of a healthy diet, higher education, and lower
smoking levels in studies conducted in the United States and
Northern Europe (36–38). Although we performed detailed
adjustment for education and smoking in our modeling, we
did not adjust for diet or other lifestyle factors that may
influence the risk of HNC, and we may not have completely
accounted for the effects of smoking. Had we been able
to do so, the associations among wine drinkers may have
been more similar to those among beer and liquor drinkers.
A second possible explanation involves the fact that wine is
more frequently consumed during meals than other alco-
holic beverages (39). The possibility of an ‘‘alcohol washing
effect’’ by the chewing and swallowing of foods has been
proposed, whereby ingestion of foods could ‘‘wash’’ alcohol
drinking and reduce the effect of ethanol and its carcino-
genic metabolites on the oral, pharyngeal, and esophageal
mucosa (40, 41). Finally, it is possible that the carcinogenic
effects of ethanol in these beverages are offset by other
anticarcinogenic compounds in wine such as resveratrol,
a phenolic compound with antioxidant properties present
in red wine that has been shown to inhibit tumor initiation
and progression in experimental studies (4). We did not have
information on the type of wine consumed (red vs. white)
for our pooled analysis; consequently, we could not inves-
tigate this hypothesis further. We caution that this last ex-
planation is speculative, given the paucity of supporting
evidence.
Some differences between regions in associations with
beer (strongest in North America), liquor (strongest in North
and Latin America), and wine (strongest in Europe) were
observed in the analysis of pure drinkers. This may reflect
differences within each broad category of beverage con-
sumption level used in the subgroup analyses (<15, 15
standard drinks per week) in the average number of drinks
per week from each region, given that the consumption
levels of beer, liquor, and wine were highest among studies
from North America, North and Latin America, and Europe,
respectively. Another possible explanation is that these dif-
ferences may indicate greater accuracy in assessing lifetime
consumption patterns (and thus less attenuation of the effect
due to misclassification) for the beverage predominant in
that region (42).
We did not observe any clear differences between bever-
age types in analyses stratified by smoking status. However,
the odds ratio estimates for each beverage type were stron-
ger and more stable among smokers compared with those
among never smokers. These differences are consistent with
effect modification between alcohol and tobacco use, evi-
dence of which has been previously reported by several
studies (43). It is biologically plausible that alcohol con-
sumption could amplify the carcinogenic effects of smok-
ing, as ethanol has been shown to increase the permeability
of oral mucosa to tobacco combustion products (44, 45).
We also did not observe meaningful differences across
beverage types with regard to their associations with HNC
at different anatomic sites. However, the odds ratio esti-
mates for alcohol consumption were stronger for cancers
of the oral cavity and pharynx than for laryngeal cancers,
irrespective of beverage type. This pattern has been previ-
ously reported in several studies and is biologically plausi-
ble given that the oral cavity and pharynx are directly
exposed to alcoholic beverages, whereas only parts of the
larynx (supraglottis and epilarynx) are exposed.
An important strength of our study is its large size. The
INHANCE Consortium, with detailed information on life-
time alcohol consumption for more than 9,000 cases and
14,000 controls from 15 case-control studies, is a unique
resource for investigating whether beer, liquor, and wine
consumptions are differentially associated with HNC risk.
In particular, the large size of this study enabled us to esti-
mate associations with alcohol consumption among individ-
uals who reported consuming only beer, wine, or liquor. As
such, it is, by far, the largest study to investigate beverage
effects among pure drinkers. Comparisons across pure-
drinker subgroups arguably represent the most informative
means of investigating whether the relative risk of HNC
from alcohol consumption differs by alcoholic beverage
type.
This study also has limitations. Foremost among these is
the presence of heterogeneity in study-specific results for
each measure of alcohol consumption examined, which lim-
its the conclusions that can be made from our pooled analy-
sis. Our inspection of study-specific findings, influence
analyses, and subgroup analyses stratifying by study charac-
teristics did not generally point to any clear sources of het-
erogeneity, although exclusion of the Tampa study from the
pooled analysis of ethanol-adjusted frequency of liquor-only
consumption resulted in a heterogeneity test statistic that was
no longer statistically significant. Differences across studies
in the wording and design of their questions assessing life-
time alcohol consumption are a potential source of hetero-
geneity. A second study limitation, which may contribute to
the observed heterogeneity, is the absence of more detailed
information regarding alcoholic beverages (e.g., red vs.
white wine consumption, beverage-specific percentage of
ethanol content for a given country, the use of nonalcoholic
‘‘mixers’’ with liquor). Such unmeasured differences among
the underlying study populations in their alcoholic beverage
consumption patterns could contribute to between-study het-
erogeneity. For example, the heterogeneity for liquor con-
sumption may be due, in part, to possible differences among
study populations in the type of liquor consumed and/or the
frequency with which liquor is consumed ‘‘straight’’ versus
‘‘mixed.’’ There is some evidence that ethanol concentration,
independent of ethanol amount, may influence HNC risk
(16). A third limitation is our inability to adjust for dietary
factors or other lifestyle characteristics that could potentially
confound our findings. Finally, we acknowledge the inherent
limitation of the retrospective case-control design for inves-
tigating the etiologic relevance of past exposures such as
lifetime alcohol consumption.
In conclusion, we observed comparable estimates of
HNC relative risk for consumption of beer, liquor and, at
high consumption levels, wine in our pooled analysis within
the INHANCE Consortium. We observed, however, a com-
paratively weaker risk at low consumption levels for wine
than for the other beverage types. Given the presence of
heterogeneity in study-specific results and the possible ex-
istence of confounding from diet and other lifestyle factors,
our findings should be interpreted with caution.
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APPENDIX
The definitions of ever alcohol drinking were as follows:
‘‘ever’’ consumed alcohol (Central Europe; Aviano, Milan,
and Italy Multicenter; France; and Switzerland studies);
>4 drinks in a year (Seattle study); 1 drink per month
for6 months in a lifetime (Los Angeles study);12 drinks
of a kind of alcohol in a lifetime (Puerto Rico study); once
or more per month (Multicenter, Latin America studies);
average 1 drink per week for 1 year (Iowa study), once
or more per week for1 year (Tampa and Houston studies);
4 times per month of beer, wine, or liquor (North Carolina
study).
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